INTS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: the trend is decisively bearish (SMA_200 > SMA_20 > SMA_5) and momentum is still deteriorating (MACD histogram negative and expanding).", "Although the stock is extremely oversold (RSI_6 ~11.5) and could bounce, there is no Intellectia buy signal to justify an immediate entry for an impatient trader.", "With no recent news catalysts and weakening financials (2025/Q3 losses widened YoY), the risk/reward is skewed against chasing a rebound at current levels."]
["Trend: Bearish (SMA_200 > SMA_20 > SMA_5), indicating sustained downside pressure across short-, medium-, and long-term timeframes.", "Momentum: MACD histogram = -0.00458 (below 0) and negatively expanding, suggesting bearish momentum is strengthening rather than stabilizing.", "Mean reversion setup: RSI_6 = 11.511 (deeply oversold). This supports the possibility of a short-term bounce, but oversold alone is not a buy trigger without confirmation.", "Key levels: Price (~0.3457 pre-market) is near support. S1 = 0.349 (currently slightly below), S2 = 0.331 (next support). Upside hurdles: Pivot = 0.378, then R1 = 0.408 and R2 = 0.426.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: no signal on given stock today.\n- SwingMax: No signal on given stock recently."]
["Technical bounce potential due to extremely oversold RSI (short-term mean reversion setup).", "Event catalyst ahead: QDEC 2025 earnings on 2026-02-12 (After Hours) can drive a volatility spike."]
increases odds of testing S2 (0.
if selling continues.", "No news in the last week to shift sentiment or provide a near-term fundamental catalyst."]
["Latest quarter: 2025/Q3.", "Revenue: 0 (no growth; effectively pre/early-commercial stage).", "Net income: -2.671M, down -23.97% YoY (loss widened).", "EPS: -0.06, down -76.00% YoY (meaningfully worse profitability per share).", "Overall: financials show no revenue base and accelerating losses, which is unfavorable support for a sustained rebound."]
["No analyst rating or price target change data was provided, so there is no visible recent Wall Street trend to confirm a bullish or improving outlook.", "Wall Street-style pros view: oversold technicals can produce sharp dead-cat bounces, and the upcoming earnings date can create a tradable volatility event.", "Wall Street-style cons view: lack of revenue, widening losses, and a micro-cap profile (market cap ~$20.57M) typically reduce institutional sponsorship and increase downside continuation risk."]
